Corundum Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $834K | Buy |
|
|||||
|
2025
Q2 | $780K | Buy |
|
|||||
|
2025
Q1 | $792K | Buy |
|
|||||
|
2024
Q4 | $366K | Sell |
|
|||||
|
2024
Q3 | $1.24M | Sell |
|
|||||
|
2024
Q2 | $1.5M | Buy |
|
|||||
|
2024
Q1 | $1.13M | Buy |
|
|||||
|
2023
Q4 | $653K | Sell |
|
|||||
|
2023
Q3 | $1.22M | Sell |
|
|||||
|
2023
Q2 | $1.36M | Sell |
|
|||||
|
2023
Q1 | $1.73M | Buy |
|
|||||
|
2022
Q4 | $1.55M | Buy |
|
|||||
|
2022
Q3 | $1.29M | Buy |
|
|||||
|
2022
Q2 | $1.51M | Buy |
|
|||||
|
2022
Q1 | $1.4M | Buy |
|
|||||
|
2021
Q4 | $1.27M | Buy |
|
|||||
|
2021
Q3 | $833K | Buy |
|
|||||
|
2021
Q2 | $728K | Buy |
|
|||||
|
2021
Q1 | $638K | Buy |
|
|||||
|
2020
Q4 | $633K | Sell |
|
|||||
|
2020
Q3 | $612K | Buy |
|
|||||
|
2020
Q2 | $522K | Sell |
|
|||||
|
2020
Q1 | $535K | Sell |
|
|||||
|
2019
Q4 | $646K | Buy |
|
|||||
|
2019
Q3 | $582K | Sell |
|
|||||
|
2019
Q2 | $702K | Buy |
|
|||||
|
2019
Q1 | $654K | Sell |
|
|||||
|
2018
Q4 | $1.1M | Buy |
|
|||||
|
2018
Q2 | $542K | Buy |
|
|||||
|
2018
Q1 | $527K | Buy |
|
|||||
|
2017
Q4 | $526K | Buy |
|
|||||
|
2017
Q3 | $518 | Buy |
|
|||||
|
2017
Q2 | $438K | Buy |
|
|||||
|
2017
Q1 | $414K | Hold |
|
|||||
|
2016
Q4 | $393K | Hold |
|
|||||
|
2016
Q3 | $410K | Sell |
|
|||||
|
2016
Q2 | $433K | Sell |
|
|||||
|
2016
Q1 | $372K | Sell |
|
|||||
|
2015
Q4 | $389K | Buy |
|
|||||
|
2015
Q3 | $358K | Buy |
|